Riskpilot← Back to searchSign inGet full accessTermino C 11379 AB
ABIn liquidationOrg 5567231088Medical specialists activities · NACE 8622Est. 20070 employees
Revenue 2023
SEK 0
EBITDA margin
—
+39% vs 2022
Equity ratio
96.4%
Financial strength
Net profit 2023
SEK 3,4M
+583% vs 2022
| Revenue | SEK 0 | — |
| EBITDA | SEK -15K | +39% |
| Net profit | SEK 3,4M | +583% |
| Total assets | SEK 13,7M | +14% |
| Equity | SEK 13,2M | +30% |
| Employees | 0 | — |
Legal name
Termino C 11379 AB
Org number
5567231088
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 februari 2007
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 36 | −37 | −11 | −25 | −15 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 36 | −37 | −11 | −25 | −15 |
| Net financials | — | — | −1 | 2 | 2 253 |
| Profit before tax | 446 | 423 | 369 | 654 | 3 785 |
| Tax | −103 | −98 | −86 | −148 | −336 |
| Net profit | 343 | 325 | 283 | 505 | 3 449 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 12 623 | 12 383 | 12 241 | 12 009 | 13 731 |
| Equity | 9 422 | 9 570 | 9 672 | 10 178 | 13 231 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 137 | 209 | 345 | 284 | 500 |
| Total debt | 137 | 209 | 345 | 284 | 500 |
EBITDA margin
-1490400.0%
This company
15.8%
Market median
-9433011% vs market
20192023
Equity ratio
96.4%
This company
38.2%
Market median
+152% vs market
20192023
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20192023
Net profit margin
344926800.0%
This company
8.1%
Market median
+4258355456% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Liquidator | Liquidator | 2024 |
| Former (2) | ||
PI Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
JO Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 11379 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Ingvar Lengstam | Chief Executive Officer | 0 companies |
| Jan Oskar Kantoft | Chief Auditor | 0 companies |
| Torbjörn Nordberg | Liquidator | 0 companies |
| Anne Catrine Volle | Deputy Board Member | 0 companies |